Last reviewed · How we verify
Assorted Licensed Hand Sanitizer Grape 01 (Licensed influenza vaccine)
The mechanism of action is not specified.
Pfizer's Assorted Licensed Hand Sanitizer Grape 01, despite its misleading name, is an influenza vaccine that holds a significant market position as one of the world's best-selling drugs. Its competitive advantage is not clearly defined due to the lack of specified mechanism and clinical trial data, but it faces strong competition from alternatives like Oseltamivir (Tamiflu) and Zanamivir (Relenza), which offer options for individuals with egg allergies. A key risk is the requirement for a PD-L1 companion diagnostic for several indications, which may limit its broader applicability and market reach. The pipeline outlook remains uncertain given the absence of ongoing clinical trials and the presence of established competitors in the influenza vaccine market.
At a glance
| Generic name | Licensed influenza vaccine |
|---|---|
| Also known as | Influenza HA, Biken, and, Fluarix tetra |
| Sponsor | Pfizer |
| Drug class | vaccine |
| Target | unknown |
| Modality | Biologic |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Mechanism of action
Unfortunately, the provided information does not specify the mechanism of action of Pfizer's licensed influenza vaccine. This makes it difficult to understand how the vaccine works at a molecular level. Further research is needed to determine the exact mechanism of action.
Approved indications
- Influenza prevention
- Influenza vaccination
- Influenza protection
Common side effects
- Injection site pain (PAIN)
- Fatigue (FATIGUE)
- Headache (HEADACHE)
- Chills (CHILLS)
- Myalgia (MUSCLE PAIN)
- Arthralgia (JOINT PAIN)
- Diarrhoea (DIARRHEA)
- Injection site erythema (REDNESS)
- Pyrexia (FEVER)
- Injection site swelling (SWELLING)
- Vomiting (VOMITING)
- Upper respiratory tract infection
Drug interactions
- Aspirin
- Warfarin
- Corticosteroids
- Immunosuppressants
- Interferons
- Thalidomide
- Zanamivir
- Oseltamivir
- Peramivir
- Amantadine
- Rimantadine
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Assorted Licensed Hand Sanitizer Grape 01 CI brief — competitive landscape report
- Assorted Licensed Hand Sanitizer Grape 01 updates RSS · CI watch RSS
- Pfizer portfolio CI